Patents by Inventor Mathilde MOSSER

Mathilde MOSSER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR OBTAINING EXTRACELLULAR VESICLES FROM BETA CELLS
    Publication number: 20250333707
    Abstract: A method for obtaining extracellular vesicles from beta cells including at least a step (i) of culturing beta cells in the form of beta cell aggregates in suspension in a cell culture medium under stirring conditions to obtain extracellular vesicles from the beta cells. Also, the extracellular vesicles, in particular the small extracellular vesicles, obtainable by the method of the invention.
    Type: Application
    Filed: May 24, 2023
    Publication date: October 30, 2025
    Applicant: ECOLE NATIONALE VETERINAIRE, AGROALIMENTAIRE ET DE L’ALIMENTATION, NANTES-ATLANTIQUE (ONIRIS)
    Inventors: Jean-Marie BACH, Steffi BOSCH, Laurence DE BEAUREPAIRE, Mathilde MOSSER
  • Si-HPMC-encapsulated insulin-producing cells for the treatment of type 1 diabetes
    Patent number: 10632154
    Abstract: The present invention relates to the use of insulin-producing cells encapsulated in silanized hydroxypropyl methylcellulose (Si-HPMC) for the treatment of type 1 diabetes. Methods and kits are also provided for restoring and/or maintaining euglycemia in type 1 diabetic patients and in type 1 prediabetic patients.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: April 28, 2020
    Assignees: Ecole Nationale Veterinaire, Chu Nantes, Universite de Nantes, Institute National de la Sante et de la Recherche Medicale
    Inventors: Jean-Marie Bach, Mathilde Mosser, Apolline Salama, Anne Moure, Xavier Leveque, Pierre Weiss, Jérôme Guicheux, Cécile Boyer, David Riochet
  • SI-HPMC-ENCAPSULATED INSULIN-PRODUCING CELLS FOR THE TREATMENT OF TYPE 1 DIABETES
    Publication number: 20180318358
    Abstract: The present invention relates to the use of insulin-producing cells encapsulated in silanized hydroxypropyl methylcellulose (Si—HPMC) for the treatment of type 1 diabetes. Methods and kits are also provided for restoring and/or maintaining euglycemia in type 1 diabetic patients and in type 1 prediabetic patients.
    Type: Application
    Filed: November 10, 2016
    Publication date: November 8, 2018
    Inventors: Jean-Marie BACH, Mathilde MOSSER, Apolline SALAMA, Anne MOURE, Xavier LEVEQUE, Pierre WEISS, Jérôme GUICHEUX, Cécile BOYER, David RIOCHET